Drugs / APN201
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01513278 Comparator | Jan → May 2012 | radiodermatitis | Apeiron Biologics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APN201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01513278 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human superoxide dismutase (rhSOD)” NCT01513278 ↗ |
| Route | Topical | “Study treatment is applied as a thin film on the irradiated area” NCT01513278 ↗ |